Epimed   Report issue

For profit Phase 4
Founded: Farmers Branch TX United States (1985)
Status: No NME R&D (1985)

Organization Overview

First Clinical Trial
2018
NCT03382821
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Epimed | Epimed International

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fractures, Bone (Phase 4)

Radiculopathy (Phase 4)

Rib Fractures (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 5